Original news and analysis on international IP policy
More than a dozen ambassadors to the World Trade Organization met today at the New Zealand mission in Geneva to discuss the state of negotiations related to intellectual property rights and trade.
The multilateral system with its different agencies dealing with specific areas is sometimes seen as incoherent in global negotiations and norm-setting as there are overlaps in competency, definition and scope, according to speakers at a side event to the recent World Trade Organization Public Forum.
Some African nations signed a protocol on the protection of traditional knowledge and folklore at the beginning of August gaining the praise of the World Intellectual Property Organization. However, a United Nations report launched in January warned against the application of western legal and economic principles to collectively owned knowledge in traditional communities.
Developed countries are looking for ways to address the ongoing lack of intellectual property enforcement and efforts to bypass international trade obligations in the four biggest emerging global economies, as well as emulation of this behaviour by other emerging economies in particular as the four countries have a stronger voice in international fora, a panel of United States trade experts said this week.
A recent Court of Justice of the European Union opinion in Monsanto Technology LLC v. Cefetra BV et al. may unintentionally inflict serious economic harm on the European biotechnology industry, argue industry attorneys Richard Peet, Vid Mohan-Ram, and Philippe Vlaemminck.
MUNICH – Some experts in Europe are coming to agreement that a tipping point might have been reached with regard to biological patents. At a conference organised this week by the “no patents on seeds” initiative on the eve of a public hearing of the European Patent Office on cases involving the patenting of broccoli and tomatoes, non-governmental representatives and farmers associations from Europe and elsewhere said there were detectable changes in American jurisprudence and European governments seem to be rethinking the biopatent issue.
A last-chance negotiation of a draft protocol text on biodiversity access and benefit-sharing has been given yet another chance as delegates parted ways on Friday in Montreal without an agreement but with a tentative plan to reconvene to try to tie it up before a major UN Convention on Biological Diversity meeting in October.
The 18th International AIDS conference opened its doors in Vienna on Sunday with a purpose of keeping the HIV issue high among international priorities in the context of a global economic crisis, and to promote universal access to treatment.
The clock was ticking with only a day to go in this week’s meeting of a UN working group on biodiversity trying to reach an agreement on a draft protocol text on access and benefit-sharing.
The last chance to complete discussions and reach an agreement on a draft protocol text on access and benefit-sharing is given to member parties of the UN Convention on Biodiversity (CBD) next week. The protocol is intended to provide a new international tool for governments against piracy of genetic resources.
Yesterday, the European Court of Justice ruled in a case pitching Monsanto against European importers of Argentinean soy meal, denying the US seed giant intellectual property rights over the exports of soy meal from Argentina to the European Union.
Lynn C. Tyler writes: The litigation provisions of the recently-enacted legislation establishing a pathway to bring biosimilars to market contain “patent” ambiguities in key areas, particularly whether the various lists of patents to be litigated are exclusive. Courts will have to resolve these issues over the next several years, likely at great (and unnecessary) expense and uncertainty to litigants.